
Rexroth Pharmaceutical Limited
About Rexroth Pharmaceutical Limited
Data last updated:
Rexroth Pharmaceutical Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2013PLC075081.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Ketankumar Hashmukhlal Trivedi and Sanjaykumar Shankarlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at A/7 First Floor Verai Estate B/H Kanchan Pharma B/H Shell Petrol Pump N.H. No 8 Aslali, Ahmedabad, Gujarat, India – 382427.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA/7 First Floor Verai Estate B/H Kanchan Pharma B/H Shell Petrol Pump N.H. No 8 Aslali, Ahmedabad, Gujarat, India – 382427
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Rexroth Pharmaceutical Limited FY 2022 filings available
Financial Statement Summary of Rexroth Pharmaceutical Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rexroth Pharmaceutical Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rexroth Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rexroth Pharmaceutical Limited
Rexroth Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketankumar Hashmukhlal Trivedi Also directs: Rexroth Builtcon LLP, Ayuway Infinity LLP | Director | 15 May 2013 | 13 Years 5 Months | Current |
| Sanjaykumar Shankarlal Shah | Director | 15 May 2013 | 13 Years 5 Months | Current |
| Sanjaykumar Hasmukhlal Trivedi | Director | 15 May 2013 | 13 Years 5 Months | Current |
Ownership and Shareholding of Rexroth Pharmaceutical Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rexroth Pharmaceutical Limited
Rexroth Pharmaceutical Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rexroth Pharmaceutical Limited
Employment history and EPFO contributions of people linked to Rexroth Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rexroth Pharmaceutical Limited
Rexroth Pharmaceutical Limited has 3 board changes on record since 2013: 3 appointments. The latest: Ketankumar Hashmukhlal Trivedi was appointed as Director on 15 May 2013.
Credit Ratings, Litigation & Regulatory Alerts for Rexroth Pharmaceutical Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rexroth Pharmaceutical Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rexroth Pharmaceutical Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rexroth Pharmaceutical Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rexroth Pharmaceutical Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rexroth Pharmaceutical Limited
Rexroth Pharmaceutical is an active public limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 May 2013 (13+ years old) and is registered under CIN U24232GJ2013PLC075081.
Rexroth Pharmaceutical has 3 current directors:
- Ketankumar Hashmukhlal Trivedi - Director
- Sanjaykumar Shankarlal Shah - Director
- Sanjaykumar Hasmukhlal Trivedi - Director
The CIN (Corporate Identification Number) of Rexroth Pharmaceutical is U24232GJ2013PLC075081. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexroth Pharmaceutical was incorporated on 15 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Ketankumar Hashmukhlal Trivedi was appointed as Director on 15 May 2013. Sanjaykumar Hasmukhlal Trivedi was appointed as Director on 15 May 2013. Sanjaykumar Shankarlal Shah was appointed as Director on 15 May 2013.
The registered office of Rexroth Pharmaceutical is at A7 First Floor Verai Estate BH Kanchan Pharma BH Shell Petrol Pump N.H. No 8 Aslali, Ahmedabad, Gujarat, India – 382427.
Rexroth Pharmaceutical has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Rexroth Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Rexroth Pharmaceutical is not listed on any stock exchange. It is an unlisted company.
The compliance status of Rexroth Pharmaceutical is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.